Wunderman wins AstraZeneca's Faslodex

Share this content:

Pharmaceuticals marketer AstraZeneca has tapped Wunderman New York to launch a consumer campaign for Faslodex, a later-stage breast cancer prescription drug for women.

The direct marketing agency competed with CommonHealth and Digitas' Medical Broadcasting Company agency for the account. Billings were not disclosed.

"This helps us broaden our portfolio with their oncology division," said Steve Zammarchi, president/CEO of Wunderman New York. "We have to create awareness for the product in the direct-to-consumer marketplace."

Wunderman New York currently handles the Arimidex and Casodex/Zoladex brands, which are part of AstraZeneca's oncology medications.

A print campaign for Faslodex will begin this summer. Call to action and theme have not yet been disclosed.

Sign up to our newsletters

Company of the Week

Since 1985, Melissa has helped thousands of companies clean, correct and complete contact data to better target and communicate with their customers. We offer a full spectrum of data quality solutions, including global address, phone, email, and name validation, identify verification - available for batch or real-time processes, in the Cloud or on-premise. Our service bureau provides dedupe, email/phone append and geographic/demographic append services for better targeting and insight. For direct mailers, Melissa offers easy-to-use address management/postal software, list hygiene services and 100s of specialty mailing lists - all with competitive pricing and excellent customer service.

Find out more here »

Career Center

Check out hundreds of exciting professional opportunities available on DMN's Career Center.  
Explore careers in digital marketing, sales, eCommerce, marketing communications, IT, data strategies, and much more. And don't forget to update your resume so employers can contact you privately about job opportunities.

>>Click Here